A comprehensive method to purify three major ANCA antigens: Proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract

被引:58
作者
Zhao, MH [1 ]
Lockwood, CM [1 ]
机构
[1] UNIV CAMBRIDGE, ADDENBROOKES HOSP, SCH CLIN MED, DEPT MED, CAMBRIDGE CB2 2SP, ENGLAND
关键词
anti-neutrophil cytoplasm autoantibody; purification; proteinase; 3; myeloperoxidase; bactericidal/permeability-increasing protein;
D O I
10.1016/0022-1759(96)00123-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Indirect immunofluorescence (IIF) techniques have shown that anti-neutrophil cytoplasm autoantibodies (ANCA) are useful serological markers for certain small vessel vasculitides and the non-vasculitic inflammatory disorders. ELISA procedures, using purified molecules as solid phase ligands, helped to identify proteinase 3 (PR3) and myeloperoxidase (MPO) as two major ANCA antigens; and recently we characterised bactericidal/permeability-increasing protein (BPI) as another important ANCA antigen. ANCA against these three antigens are associated with different clinical disorders. Therefore purified antigens are needed to determine these different autoantibody specificities in order to help diagnosis and guide treatment. Here we describe a method using Orange-A dye ligand chromatography and cation exchange chromatography for the sequential purification of PR3, MPO and BPI, from the same starting material, an acid extract of normal human neutrophil granules. After separation the three antigens were free of contamination by each other and no traces were found of other known minor ANCA antigens.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 27 条
[1]   ANTILACTOFERRIN ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS ARE ASSOCIATED WITH VASCULITIS [J].
COREMANS, IEM ;
HAGEN, EC ;
DAHA, MR ;
VANDERWOUDE, FJ ;
VANDERVOORT, EAM ;
KLEIJBURGVANDERKEUR, C ;
BREEDVELD, FC .
ARTHRITIS AND RHEUMATISM, 1992, 35 (12) :1466-1475
[2]   RELATIONSHIP BETWEEN DISEASE-ACTIVITY AND ANTINEUTROPHIL CYTOPLASMIC ANTIBODY CONCENTRATION IN LONG-TERM MANAGEMENT OF SYSTEMIC VASCULITIS [J].
DEOLIVIERA, J ;
GASKIN, G ;
DASH, A ;
REES, AJ ;
PUSEY, CD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) :380-389
[3]   THE BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI), A POTENT ELEMENT IN HOST-DEFENSE AGAINST GRAM-NEGATIVE BACTERIA AND LIPOPOLYSACCHARIDE [J].
ELSBACH, P ;
WEISS, J .
IMMUNOBIOLOGY, 1993, 187 (3-5) :417-429
[4]   AUTOANTIBODIES TO LACTOFERRIN AND HISTONE IN SYSTEMIC VASCULITIS IDENTIFIED BY ANTIMYELOPEROXIDASE SOLID-PHASE ASSAYS [J].
ESNAULT, VLM ;
SHORT, AK ;
AUDRAIN, MAP ;
JONES, SJ ;
MARTIN, SJ ;
SKEHEL, JM ;
LOCKWOOD, CM .
KIDNEY INTERNATIONAL, 1994, 46 (01) :153-160
[5]   ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES WITH SPECIFICITY FOR MYELOPEROXIDASE IN PATIENTS WITH SYSTEMIC VASCULITIS AND IDIOPATHIC NECROTIZING AND CRESCENTIC GLOMERULONEPHRITIS [J].
FALK, RJ ;
JENNETTE, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1651-1657
[6]   ANTIBIOTIC PEPTIDES AND SERINE PROTEASE HOMOLOGS IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES - DEFENSINS AND AZUROCIDIN [J].
GABAY, JE ;
ALMEIDA, RP .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (01) :97-102
[7]   WEGENER GRANULOMATOSIS AUTOANTIBODIES IDENTIFY A NOVEL DIISOPROPYLFLUOROPHOSPHATE BINDING-PROTEIN IN THE LYSOSOMES OF NORMAL HUMAN-NEUTROPHILS [J].
GOLDSCHMEDING, R ;
VANDERSCHOOT, CE ;
HUININK, DT ;
HACK, CE ;
VANDENENDE, ME ;
KALLENBERG, CGM ;
VONDEMBORNE, AEGK .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1577-1587
[8]  
GOLDSCHMEDING R, 1989, APMIS S6, V97, P48
[9]   ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES, AUTOANTIGENS, AND SYSTEMIC VASCULITIS [J].
GROSS, WL ;
CSERNOK, E ;
HELMCHEN, U .
APMIS, 1995, 103 (02) :81-97
[10]  
HAGEN EC, 1993, J IMMUNOL METHODS, V159, P1